180,000
Participants
Start Date
July 27, 2023
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
TabCAT Brain Health Assessment Clinical Pathway
Primary care providers concerned that their patients are exhibiting signs of cognitive decline will refer them to clinical associates who will then perform the TabCAT-BHA tablet-based test. The TabCAT-BHA paradigm comprises 7-10 minutes of tablet-based testing and an optional 3-minute self-administered informant survey captures behavioral symptoms and change from baseline. The results are available to the PCP in the EMR along with turnkey guidance to evaluate for reversible causes, identify and involve a care partner, make and disclose diagnosis, provide community and educational resources, and make medical referrals as appropriate. Nursing support is available to support the PCP in making the diagnosis and to consult to the family via telephone post-diagnosis to address immediate care needs.
RECRUITING
Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena
Kaiser Permanente
OTHER
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
University of California, San Francisco
OTHER